Diluted HEPS 601.5cps (+9.6% y-y).
Revenue growth of 5.6% y-y to R9.6bn, supported by price realisation of 4.9% and a mix benefit of 1.5%.
Group GPM declined by 150bps to 33.4%.
Total expenses grew 5.0% y-y, with expenses-to-sales decreasing by 20bps to 22.3%.
OPM declined by 140bps to 11.0%.
Dividend of 275 cps (FY23: 250 cps).
Net cash improved to R89.4m (FY23: R81.9m).
AIP repurchased 6 million shares during the period.
Organic volumes declined by 0.8% y-y, a recovery from the 5.0% y-y decline experienced in 1H24.
2H24 benefited from increased demand for winter products, driven by a rise in cold and flu cases and other respiratory illnesses.
The Consumer division acquired the Dermopal brand effective 1 July 2024, which consists of moisturising sunscreen. This will augment the division’s existing skincare/suncare product offering.
